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 Introduction 
 Increasing or high prevalence of cannabis use among 
younger people raises questions about negative conse-
quences of cannabis use for the individual and his envi-
ronment. Problematic cannabis use is becoming a chal-
lenge for public health, but there is no generally accepted 
definition of what constitutes problematic use. Usually 
only general statements, such as the comment that prob-
lematic use is that which leads to negative consequences 
on a social or health-related level  [1] , can be found. Hence, 
there is an increasing demand for appropriate instru-
ments to assess problematic use patterns. One instrument 
to screen for cannabis abuse or dependence in a quick and 
easy way is the Cannabis Use Disorders Identification Test 
(CUDIT)  [2] . There has been no evaluation of the CUDIT 
in large-scale general population samples yet, so the pres-
ent study provides such an evaluation for Switzerland.
 Several tools for the assessment of problematic canna-
bis use exist but they are of varying quality and many lack 
validation  [1, 3] . In 2003, the CUDIT was constructed by 
modifying the Alcohol Use Disorders Identification Test 
(AUDIT)  [4] , and its validity was examined in a small 
sample (n = 53) of cannabis-using alcohol-dependent 
outpatients in New Zealand  [2] . Taking DSM-IV criteria 
as the ‘gold standard’, it was found that the CUDIT was 
superior to a simple frequency-of-use measure. The cut-
off value of eight points, as used for the AUDIT  [4] , ap-
peared to be suitable in that sample  [2] . Two years later, a 
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German version of the CUDIT was validated in a sample 
of university students (n = 171). The investigator com-
pared the CUDIT to different external criteria (e.g. to a 
German version of the Severity of Dependence Scale). She 
found an ideal cut-off value for cannabis use disorders of 
between three and five  [5] .
 Discussions about  problematic cannabis use are inevi-
tably confounded with general questions about the na-
ture of cannabis-related problems. Every instrument that 
is chosen to measure problematic cannabis use relies on 
a ‘social construct’  [6] of what is seen to be ‘normal’ and 
what is not.
 However, different experts agree on at least a few 
points: the scientific literature shows evidence for the im-
pairing effect of cannabis on cognitive functioning, con-
centration, and on educational and working performance 
 [7, 8] . Impairing effects during acute intoxication are un-
doubted, while possible long-term effects of cannabis on 
cognitive functioning are controversial  [9, 10] . Conse-
quently, using cannabis before work or school is com-
monly considered to be problematic  [11, 12] . In connec-
tion with the impairing effect of cannabis on cognitive 
functioning and concentration, many recent studies show 
evidence of the decreased capacities of intoxicated motor 
vehicle drivers  [13, 14] and conclude that driving while 
under the influence of cannabis must be considered prob-
lematic  [12] . Some studies found a strong correlation be-
tween cannabis use and depression  [15–17] , whereas oth-
ers did not  [18, 19] . While the  causal path from cannabis 
use to depression is hardly agreed upon  [20, 21] , it is often 
argued that cannabis use is problematic for people with 
an unstable mental health condition, or if it is used as a 
means of self-medication for psychological troubles like 
depression, desperation, or anxiety  [12, 22] . Cannabis us-
ers with coping motives show lower mental health scores, 
more symptoms of psychopathology, and more psycho-
social distress than cannabis users with social motives 
 [23, 24] . Some researchers have argued that there are ad-
vantages to directness when screening for substance use 
disorders and thus proposed to rely on the concerned 
persons own general self-evaluation of whether a certain 
pattern of cannabis use causes them problems  [25] .
 The AUDIT was conceptualized to screen for  hazard-
ous  or harmful consumption patterns, before dependence 
and serious harm have occurred  [26] . To date, however, 
the CUDIT was tested for its ability to screen for  abuse  or 
dependence only  [2] . Thus, the present study measured 
the CUDIT’s ability to screen for  problematic cannabis 
use in a broader sense, including abuse and dependence, 
but also hazardous and harmful use.
 Accordingly, our study used the above mentioned, 
agreed-upon concepts of problematic cannabis use to 
evaluate the CUDIT:  smoking cannabis at work/in school , 
smoking cannabis and driving ,  depressive symptoms ,  smok-
ing cannabis to cope , and  self-evaluation . Our study exam-
ined the screening instrument’s psychometric properties 
and compared it to these concepts in a general population 
sample of Swiss adolescent and young adults. Addition-
ally, we wanted to determine a suitable cut-off value to 
discriminate problematic from ‘nonproblematic’ users.
 Method 
 Study Design and Sample 
 The  Swiss Cannabis Monitoring Study was commissioned and 
financed by the Swiss Federal Office of Public Health. It consisted 
of a market study, a sentinel system (repeated focus groups with 
experts), and a longitudinal population survey. This survey col-
lected data about amount, social and health consequences of can-
nabis use, as well as attitudes towards cannabis and its legality. 
The following analyses were based on the longitudinal survey’s 
first wave, conducted in 2004. The sample consisted of 13- to 29-
year-old Swiss inhabitants who were able to communicate in Ger-
man, French, or Italian.
 A representative sample of 5,025 adolescents and young adults 
was randomly drawn, stratified by region (two-stage selection 
procedure: (1) households, (2) persons within a household), and 
interviewed by means of computer-aided telephone interviews by 
the Swiss social research institute ‘IBSF’. The questionnaire con-
sisted of 103 items, with almost half dedicated to cannabis (46 
items). The response rate was 62%. Within the sample, 593 (11.8%) 
were actual cannabis users, i.e. they used cannabis at least once 
during the 6 months preceding the interview. The CUDIT was 
completed by actual cannabis users, only. Within this subsample 
of actual users, 64.2% were male and 35.8% female; 54.5% from 
German, 34.9% from French, and 10.6% from Italian speaking 
regions; 68.8% were underage (13–18 years old) and 31.2% were 
19–29 years old; mean age was 18.2 years. The younger age group 
was oversampled to obtain a sufficient proportion of underage 
cannabis users. The subsample consisted of 12.8% daily or almost 
daily users; 31.2% used cannabis on a weekly, 31.0% on a monthly 
basis, and 25.0% had used cannabis at least once during the last 6 
months, but not on a monthly basis.
 Variables 
 CUDIT. The CUDIT consists of 10 Items (appendix 1). On each 
item, points are distributed according to the given answers and 
added up to a total CUDIT score. Possible scores can range from 
0 to 40 points.  The following variables ( table 1 ) are the ‘accepted 
concepts of problematic cannabis use’. These variables are not 
part of the CUDIT, but might potentially be associated with can-
nabis-related problems (depressive symptoms) or deal obviously 
with it (e.g. smoking and driving).
 Smoking Cannabis at Work/in School.  People who use cannabis 
were asked how often they use it ‘at work or in school’. Possible an-
swers originally ranged from ‘often’, ‘frequent’, ‘seldom’, to ‘never’, 
but were dichotomized into ‘often/frequent’ and ‘seldom/never’.
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 Smoking Cannabis and Driving.  This variable measured the 
frequency of driving a motor vehicle within 2 h after having used 
cannabis. The five-point scale was dichotomized into ‘at least 
once’ during the 6 months preceding the interview or ‘never’. Le-
gal age limit for driving a motor vehicle, i.e. a moped, is 14 years 
in Switzerland. Nevertheless, 13-year-olds were not excluded 
from the analyses since one third of those in this age group re-
sponded positively to the question.
 Depressive Symptoms. Interviewed persons were asked if they 
had experienced a period of 2 or more weeks within the last 12 
months, where they felt ‘sad, dejected, uninterested or depressed’. 
Possible answers were ‘yes’ or ‘no’.
 Smoking Cannabis to Cope.  If cannabis is used ‘to deal with 
stress’, ‘if feeling lonely’, or ‘if feeling down’ it serves as a coping 
strategy. The three items were summed up to build an index of 
‘coping’. Each single item was originally measured on a four-point 
scale. If on at least one of the three items the answer was ‘often’ or 
‘frequent’, the coping variable scored positive. The final index had 
two possible values; either ‘coping’ or ‘no coping’.
 Self-Evaluation.  People were asked if they ever had problems 
related to cannabis (without specifying what kind of problems). 
The variable was dichotomous with the possible answers: ‘yes’ and 
‘no’.
 Data Analysis 
 Analyses were performed using SPSS for Windows and M-
Plus for the confirmatory factor analysis. Missing values on the 
10 CUDIT items ranged from 0 (item 1) to 49 (item 2) and were 
imputed by means of Markov Chain-Monte-Carlo estimates  [27] 
in PRELIS. Imputation involved replacing an incomplete obser-
vation with complete information based on an estimation of the 
true value drawn from observing other cases with similar answer-
ing patterns.
 We did not take the complex sampling into account, firstly 
because the primary aim of the study was analytical (associations 
between variables) and not descriptive (prevalence estimates) 
 [28] , secondly because only a subsample was used and not the full 
sample for which disproportionate weights existed, and thirdly 
because no sample survey software was available for some of the 
statistical routines. However, because of the stratified design 
which is more efficient than a simple random sample, standard 
errors and therefore confidence intervals should be even more 
conservative.
 First, for all 10 CUDIT items as a whole, mean, standard de-
viation, median, mode as well as minimum and maximum total 
scores were calculated. To present the psychometric properties of 
the single CUDIT items, each item’s mean score and standard de-
viation was reported. To assess the importance of each item (‘item 
difficulty’), the proportion of the mean item to the mean total 
score, frequency of each item’s positive scorings, and the propor-
tion of CUDIT-positive screened individuals if one item was de-
leted are described in percentages. Confirmatory factor analysis 
with categorical factor indicators, based on tetrachoric correla-
tion coefficients, was performed to establish the construct valid-
ity of the CUDIT as a single factor model. Subsequently, internal 
consistency of the CUDIT scale was assessed by Cronbach’s alpha 
if an item was deleted. To further assess internal consistency, the 
corrected item-total correlation was calculated for each item.
 Logistic regression analyses were performed to test the CU-
DIT’s ability to identify problematic cannabis use according to the 
five external criteria. In addition, receiver operating characteristic 
(ROC) curves were used to test the CUDIT’s discriminative abil-
ity between problematic and ‘nonproblematic’ cannabis users and 
to determine the most appropriate cut-off score for use as an indi-
cator of problematic cannabis use, by taking the accepted concepts 
as reference, again. ROC curves show the relationship between 
sensitivity (proportion of true positives) and specificity (propor-
tion of true negatives) according to reference standards across the 
full range of possible cut-off values. By calculating the area under 
the ROC (AUC), the ability of the CUDIT to discriminate between 
problematic and ‘nonproblematic’ users (according to the five ref-
erence concepts of problematic use) was tested. If ROC represents 
a straight diagonal line, the AUC is 0.5, which indicates that a test 
would not discriminate more than by chance. As a general rule, an 
AUC between 0.7 and 0.8 is considered an acceptable and an AUC 
between 0.8 and 0.9 an excellent discrimination  [29] . As proposed 
by Hosmer and Lemeshow  [29] , optimal cut-off values, according 
to each of the five reference variables, were defined as the point 
Table 1. Concepts of problematic cannabis use (n = 593, total)
Concepts Questions Positive
if answer is …
Frequency
%
n
(valid)
Smoking cannabis
at work/in school
If you use cannabis, how often do you use it … at work/in school/
apprenticeship?
often, frequently 7.64 589
Smoking cannabis 
and driving
How often, during the past 6 months, have you been driving a car, 
motorbike, moped within 2 hours after having used cannabis?
at least once 23.55 586
Depressive
symptoms
Do you remember having lived a period during the last 12 months, 
where you felt sad, dejected, uninterested or depressed, that lasted 
for 2 or more weeks?
yes 40.03 592
Smoking cannabis
to cope
If you use cannabis, how often do you use it … if you are stressed 
(or) … if you feel lonely (or) … if you are not doing well?
often, frequently 34.66 577
Self-evaluation Did you ever have any problems with cannabis? yes 19.46 591
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where sensitivity and specificity curves cross. The exact crossing 
points were obtained by means of graphic illustrations.
 Finally, the prevalence of problematic cannabis use among all 
actual users, according to the different calculated CUDIT cut-
offs, was computed.
 Results 
 Psychometric Properties of the CUDIT 
 Subjects scored at an average (mean) of 6.4 points on 
the total CUDIT. Standard deviation was 5.4 and median 
was five points. The majority of the subjects got one
CUDIT point; maximum points reached was 31.
 As indicated in  table 2 (column 1) the largest part of 
the total CUDIT score was contributed by item 1 (fre-
quency of use) followed by item 10 (concerned others). In 
contrast, the contributions of items 6 (morning use) and 
9 (injuries) were the weakest. However, for all but items 1 
and 10, item difficulties were high with rates of positive 
scoring  ! 10% (column 4). The proportion of CUDIT-
screened positive individuals if one item was deleted (col-
umn 5) indicated the importance of item 1 again: if this 
item was deleted, only 21.25% of all actual cannabis users 
were screened positive compared to 33.20% positive 
screened without deleting any item. A similar decline in 
positively screened users would appear by deleting item 
10. In contrast, item 6 could be deleted with only a small 
loss in positive screened cannabis users.
 Confirmatory factor analysis (column 6) yielded high 
factor loadings for items 1 and 4 (not able to stop). Item 9 
performed very weakly, followed by item 2 (usual hours 
being stoned) and item 5. Internal consistency for the to-
tal CUDIT score, measured by Cronbach’s alpha, was sat-
isfactory (0.72). A modest improvement occurred when 
item 9 was deleted (column 7). However, without item 1, 
item 3 (stoned for 6 or more hours) or item 8 (memory/
concentration problems) the internal consistency de-
clined remarkably. Finally, corrected item-total correla-
tions (column 8) were high for items 1 and 3, while they 
were rather low for items 9 and 2.
 Comparison of the CUDIT to External Criteria 
 As shown in  table 3 , all five external criteria were asso-
ciated to the CUDIT. The strongest association existed be-
tween the CUDIT and the user’s  self-evaluation : individu-
als who were identified by the CUDIT as problematic us-
ers had a more than fivefold risk to ever have had prob-
lems with cannabis according to their explicit declaration 
(OR = 5.5, p < 0.001). The weakest, but still statistically sig-
nificant, association existed between the CUDIT and the 
criteria of  depressive symptoms (OR = 1.5, p < 0.05 ).
 The AUC was acceptable (i.e. AUC  6 0.7) for three out 
of the five concepts ( table 4 ): best discriminative ability 
was shown for  self-evaluation followed by  smoking to cope 
or  smoking at work/in school . However, the discrimina-
tive ability of the CUDIT for the other two concepts was 
insufficient, although still significantly different from 
the null hypothesis (AUC = 0.5).
 In  table 5 , a list of sensitivity and specificity across the 
full range of possible cut-off points for each of the con-
Table 2. Psychometric properties of the individual CUDIT items (n = 593)
Item Label Basic statistics Importance of the single items (difficulty) Internal consistency 
(discriminative power)
mean score
per item
(points)
standard 
deviation
(points)
proportion of 
mean item-score 
to mean total-
scorea, %
frequency of 
item’s high 
scoringb,
%
proportion of CUDIT 
positivec screened 
individuals if item 
deletedd, %
confirmatory 
factor
analysis
Cronbach’s 
alpha 
if item 
deletedf
corrected 
item-total 
correlation
1 Frequency of use 2.08 1.12 32.40 32.38 21.25 0.77e 0.66 0.55
2 Usual hours being stoned 0.39 0.81 6.12 3.71 31.37 0.41*** 0.71 0.23
3 Stoned for 6 or more hours 0.63 0.94 9.83 6.75 29.51 0.72*** 0.67 0.53
4 Not able to stop 0.30 0.84 4.73 5.06 31.70 0.77*** 0.68 0.49
5 Failed to do what expected 0.28 0.70 4.34 2.70 31.53 0.53*** 0.70 0.37
6 Morning use 0.25 0.74 3.84 3.37 32.21 0.71*** 0.69 0.45
7 Guilt/remorse 0.41 0.85 6.39 4.72 29.68 0.56*** 0.70 0.35
8 Memory/concentration problems 0.72 1.04 11.22 8.77 28.50 0.71*** 0.67 0.52
9 Injuries 0.26 0.98 3.99 6.41 31.37 0.13 0.74 0.07
10 Concerned others 1.10 1.79 17.14 27.49 24.79 0.59*** 0.71 0.41
a Mean CUDIT total-score: 6.42. b High scoring: if at least three points per item. c Positive: if at least eight points on the total CUDIT. d Proportion of 
positive screened individuals for the total CUDIT: 33.20 %. e Reference category. f Cronbach’s alpha for the total CUDIT: 0.72. *** p < 0.001.
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cepts is presented. Concerning the three concepts for 
which the CUDIT’s discriminative ability was acceptable, 
the optimal cut-off (i.e. where sensitivity and specificity 
curves cross) was either eight  (smoking at work/in school) , 
seven  (self-evaluation) or six  (smoking to cope) . While 
there is one third (33.22%) of problematic users with the 
cut-off at eight CUDIT points, there would be nearly half 
of actual cannabis users (44.86%) defined as problematic 
users, if cut-off was set with six points.
 Discussion 
 There is currently no agreed-upon definition of prob-
lematic cannabis use that could be used for screening pur-
poses. Comparative studies such as the one conducted by 
the European Monitoring Centre for Drugs and Drug Ad-
diction  [30] commonly use prevalence estimates such as 
past 30 days use. The lack of an agreed-upon definition is 
surprising as cannabis can undoubtedly have some nega-
tive consequences on physical and mental health, and 
numbers of cannabis treatment demands have been in-
creasing all over the world  [31] . Several indicators for prob-
lematic drug use in general, and thus also cannabis, have 
been discussed, e.g. the ‘treatment multiplier’ or ‘police 
data multiplier’ or just prevalence of regular (daily) use 
 [31] . All these indicators have weaknesses, and a more 
commonly agreed-on comprehensive indicator would 
make comparative research and reporting easier.
 Additionally, an indicator for problematic cannabis 
use that could be used before treatment is urgently need-
ed and would be particularly useful to aid, for example, 
in the design of brief interventions for problematic users 
that have not yet entered the treatment system. Such users 
have to be identified by screening. In the alcohol field, an 
indicator that can be used for both monitoring and 
Table 3. Association between CUDIT and five concepts of problematic cannabis use (n = 593, total)
Concepts Answers According to CUDIT (cut-off 8) Logistic regression
nonproblematic
use, %
problematic 
use, %
n (valid)
= 100%
B SE B OR
Smoking at work/in school often/frequently 35.6 64.4 45 1.41 0.32 4.09***
seldom/never 69.3 30.7 544
Smoking and driving at least once 52.2 47.8 138 0.82 0.20 2.27***
never 71.2 28.8 448
Depressive symptoms yes 61.2 38.8 237 0.41 0.18 1.51*
no 70.4 29.6 355
Smoking to cope often/frequently 43.0 57.0 200 1.67 0.19 5.34***
seldom/never 80.1 19.9 377
Self-evaluation yes 34.8 65.2 115 1.70 0.22 5.50***
no 74.6 25.4 476
Logistic regression = independent variable: problematic cannabis use according to CUDIT (1 = yes, 0 = no). Dependent variables =
problematic cannabis use according to five concepts of problematic cannabis use (1 = yes, 0 = no). * p < 0.05, *** p < 0.001.
Table 4. ROC curve analyses (n = 593)
Concepts Asymptotic
sign.a 
Area under
the ROC
Asymptotic 95% CI
lower bound upper bound
Smoking at work/in school 0.000 0.740 0.668 0.812
Smoking and driving 0.000 0.631 0.578 0.684
Depressive symptoms 0.004 0.569 0.522 0.616
Smoking to cope 0.000 0.761 0.722 0.801
Self-evaluation 0.000 0.770 0.724 0.817
a If testing difference to null hypotheses (area under the ROC = 0.5).
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screening of problematic alcohol use, namely the AUDIT, 
is widely accepted and has demonstrated its usefulness in 
clinical settings as well as in general population surveys 
in many countries  [26, 32] . A similarly constructed indi-
cator has been suggested for cannabis, the CUDIT.
 Psychometric testing, as described in our study, has 
demonstrated the general usefulness of the CUDIT, but 
also that there is some room left for improvement as 
Chronbach’s alpha was moderate at 0.72  [33] . Two items 
had rather low loadings on a unidimensional construct, 
and their deletion would reduce Chronbach’s alpha only 
very slightly or even increase it. They also correlated 
poorly with the total scale. Potential reasons for the mod-
erate performance of these items –  cannabis related in-
jury (item 9) and  usual hours being stoned (item 2) as an 
indicator for quantity of cannabis use – will be discussed 
below.
 First, though it is widely accepted today that cannabis 
use can impair driving abilities  [12–14, 34] , it has also 
been argued that in practice there might not be any de-
crease in driving abilities due to the compensation of 
more cautious driving by cannabis-impaired drivers  [31, 
35] . Additionally, a triggering effect of cannabis use on 
violent behavior (leading to injuries) has not been proven. 
On the contrary, some studies even suggest a decrease in 
aggression for cannabis-intoxicated individuals  [36, 37] . 
It might therefore be the case that the injury item that was 
directly transferred from the Alcohol Use Disorders Iden-
tification Test is more appropriate for alcohol than for 
cannabis-related problems.
 Second, it might be challenged whether the  number of 
hours being stoned is an adequate indicator for quantity 
of cannabis use; the more one is accustomed to cannabis 
use, the less feelings of being stoned might occur with the 
same amount of cannabis  [38, 39] . However, if that was 
so, item 3 should have suffered similar difficulties, which 
was not the case. In addition, it has been shown that 
quantity of cannabis use is less predictive for dependence 
than frequency of use  [40] .
 Despite the drawbacks with these two items, the
CUDIT total scores were related to external criteria, i.e. 
five accepted concepts of problematic cannabis use. These 
clear associations demonstrate the potential of the
CUDIT. ROC analysis suggested that a cut-off value of 
eight (same as the AUDIT  [4] or as derived for the CUDIT 
from a sample of alcohol dependent outpatients  [2] ) might 
be too high for a general population screening. Our anal-
yses suggested a cut-off between six and eight.
Table 5. Sensitivity, specificity, and optimal cut-off points, % (n = 593)
CUDIT score Smoking at work/in school Smoking and driving Depressive symptoms Smoking to cope Self-evaluation
sensitivity specificity sensitivity specificity sensitivity specificity sensitivity specificity sensitivity specificity
1 1.000 0.000 1.000 0.000 1.000 0.000 1.000 0.000 1.000 0.000
2 0.978 0.184 0.906 0.199 0.873 0.208 0.975 0.247 0.965 0.210
3 0.933 0.309 0.848 0.335 0.759 0.330 0.920 0.403 0.948 0.353
4 0.889 0.426 0.703 0.435 0.646 0.439 0.845 0.538 0.870 0.473
5 0.844 0.494 0.667 0.511 0.578 0.504 0.750 0.589 0.835 0.546
6 0.756 0.575 0.580 0.589 0.502 0.589 0.660 0.668 0.774 0.632
7 0.711 0.642 0.522 0.656 0.439 0.654 0.625 0.751 0.713 0.697
8 0.644 0.693 0.478 0.712 0.388 0.704 0.570 0.801 0.652 0.746
9 0.578 0.733 0.428 0.752 0.333 0.738 0.500 0.822 0.591 0.782
10 0.489 0.787 0.377 0.810 0.266 0.786 0.430 0.873 0.530 0.836
11 0.444 0.822 0.333 0.844 0.241 0.831 0.375 0.899 0.478 0.870
12 0.400 0.846 0.304 0.868 0.207 0.851 0.335 0.918 0.435 0.891
13 0.400 0.869 0.254 0.882 0.190 0.876 0.305 0.936 0.400 0.910
14 0.333 0.901 0.174 0.902 0.152 0.907 0.245 0.955 0.313 0.931
15 0.333 0.921 0.145 0.917 0.148 0.935 0.220 0.971 0.261 0.941
16 0.267 0.938 0.138 0.942 0.110 0.944 0.165 0.973 0.209 0.954
etc. 
Optimala
cut-off
               8               6               6              6              7
a Statistical optimal cut-off is where sensitivity and specificity curves cross [29]. Proportion of positive screened users in the Swiss 
sample: cut-off 6–44.86%, cut-off 7–38.45%, cut-off 8–33.22%.
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 Our findings must be interpreted in the face of at least 
one relevant limitation: The Swiss Cannabis Monitoring 
Study was primarily conceptualized for epidemiological 
reasons, not for doing psychometric analyses. Therefore, 
an approved ‘gold standard’ – e.g. DSM IV criteria for 
cannabis abuse and dependence  [41] or ICD 10 criteria for 
harmful use  [42] – was not included in the questionnaire. 
Thus, our evaluation of the CUDIT had to be settled by 
other references, i.e. items about smoking cannabis at 
work or in school, smoking cannabis and driving, etc. 
However, we assessed the usefulness of the CUDIT as a 
screener for  problematic cannabis use , a broader concept 
than dependence or abuse, and no approved ‘gold stan-
dard’ exists for problematic cannabis use at all.
 Based on our findings, we conclude that the CUDIT 
has the potential to be used as a comprehensive indicator 
for problematic cannabis use. However, probably due to 
some items with poor performance, sensitivity and spec-
ificity were rather low. There is a need to revise these 
items and to repeat psychometric testing in order to see 
whether such a revised screener would perform better.
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Appendix 1. Th e Cannabis Use Disorders Identifi cation Test (CUDIT) 
Have you used any cannabis over the past 6 months? If YES, 
please answer the following questions about your cannabis use:
Answers
1 How often do you used cannabis? never (0), monthly or less (1), 2–4 times a month (2), 
2–3 times a week (3), 4 or more times a week (4)
2 How many hours were you ‘stoned’ on a typical day when you had 
been using cannabis?
1 or 2 (0), 3 or 4 (1), 5 or 6 (2), 7 to 9 (3), 10 or more 
(4)
3 How often were you ‘stoned’ for 6 or more hours? never (0), less than monthly (1), monthly (2), weekly 
(3), daily or almost daily (4)
4 How often during the past 6 months did you find that you were not 
able to stop using cannabis once you had started?
never (0), less than monthly (1), monthly (2), weekly 
(3), daily or almost daily (4)
5 How often during the past 6 months did you fail to do what was 
normally expected from you because of using cannabis?
never (0), less than monthly (1), monthly (2), weekly 
(3), daily or almost daily (4)
6 How often during the past 6 months did you need to use cannabis
in the morning to get yourself going after a heavy session of using 
cannabis?
never (0), less than monthly (1), monthly (2), weekly 
(3), daily or almost daily (4)
7 How often during the past 6 months did you have a feeling of guilt 
or remorse after using cannabis?
never (0), less than monthly (1), monthly (2), weekly 
(3), daily or almost daily (4)
8 How often during the past 6 months have you had a problem with 
your memory or concentration after using cannabis?
never (0), less than monthly (1), monthly (2), weekly 
(3), daily or almost daily (4)
9 Have you or someone else been injured as a result of your use of 
cannabis over the past 6 months?
no (0), yes (4) 
10 Has a relative, friend or a doctor or other health worker been 
concerned about your use of cannabis over the past 6 months?
no (0), yes (4)
From [2]. Points per answer are indicated in brackets. German, French, and Italian versions of the CUDIT are available from the au-
thors.
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